Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Cancer Immunotherapy at the Crossroads : How Tumors Evade Immunity and What Can Be Done, PDF eBook

Cancer Immunotherapy at the Crossroads : How Tumors Evade Immunity and What Can Be Done PDF

Edited by James H. Finke, Ronald M. Bukowski

Part of the Current Clinical Oncology series

PDF

Please note: eBooks can only be purchased with a UK issued credit card and all our eBooks (ePub and PDF) are DRM protected.

Description

Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction.

The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis.

They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ.

Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients' immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells.

Information

Information

Also in the Current Clinical Oncology series  |  View all